The need to incorporate aged animals into the preclinical modeling of neurological conditions-Reference-Cited by-同舟云学术

The need to incorporate aged animals into the preclinical modeling of neurological conditions

Published:2020-02 Issue: Volume:109 Page:114-128
ISSN:0149-7634
Container-title:Neuroscience & Biobehavioral Reviews
language:en
Short-container-title:Neuroscience & Biobehavioral Reviews

Author:

Sun Mujun,McDonald Stuart J.,Brady Rhys D.,Collins-Praino Lyndsey,Yamakawa Glenn R.,Monif Mastura,O’Brien Terence J.,Cloud Geoffrey C.,Sobey Christopher G.,Mychasiuk Richelle,Loane David J.,Shultz Sandy R.

Funder

National Health and Medical Research Council of Australia

Publisher

Elsevier BV

Subject

Behavioral Neuroscience,Cognitive Neuroscience,Neuropsychology and Physiological Psychology

Reference282 articles.

1. How to translate time: the temporal aspects of rodent and human pathobiological processes in traumatic brain injury;Agoston;J. Neurotrauma,2019

2. Cis P-tau is induced in clinical and preclinical brain injury and contributes to post-injury sequelae;Albayram;Nat. Commun.,2017

3. Oxidative stress and its role in the pathogenesis of ischaemic stroke;Allen;Int. J. Stroke,2009

4. Elevated oxidative stress in the brain of senescence-accelerated mice at 5 months of age;Álvarez-García;Biogerontology,2006

5. Hemorrhagic and ischemic strokes compared: stroke severity, mortality, and risk factors;Andersen;Stroke,2009

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Osteoporosis and Alzheimer´s disease (or Alzheimer´s disease and Osteoporosis);Ageing Research Reviews;2024-08

2. More than a number: Incorporating the aged phenotype to improve in vitro and in vivo modeling of neurodegenerative disease;Brain, Behavior, and Immunity;2024-07

3. CCR2+ monocytes promote white matter injury and cognitive dysfunction after myocardial infarction;Brain, Behavior, and Immunity;2024-07

4. High-Fat Diets in Animal Models of Alzheimer’s Disease: How Can Eating Too Much Fat Increase Alzheimer’s Disease Risk?;Journal of Alzheimer's Disease;2024-01-30

5. Neuronanomedicine for Alzheimer’s and Parkinson’s disease: Current progress and a guide to improve clinical translation;Brain, Behavior, and Immunity;2024-01